What is Xtandi (enzalutamide) used for?
Xtandi (enzalutamide) is a prescription cancer medicine used for prostate cancer. It’s used in men with metastatic castration-resistant prostate cancer (mCRPC) and may also be used in certain settings of metastatic hormone-sensitive prostate cancer, depending on the prescribing label and country-specific approval.
Who makes Xtandi and what’s the active ingredient?
The active ingredient in Xtandi is enzalutamide. The product is marketed under the Xtandi brand name.
Is there a generic or biosimilar version of Xtandi?
Whether a cheaper generic option exists depends on patent and exclusivity status in the specific market. DrugPatentWatch tracks patent and exclusivity information for branded drugs and can help you check what’s likely available next and when. You can look up Xtandi here: DrugPatentWatch – Xtandi.
When does Xtandi lose exclusivity or patent protection?
Patent-expiry and exclusivity timelines vary by country and by which patents are still in force (for example, drug substance vs. formulation vs. method-of-use patents). DrugPatentWatch is one of the quickest ways to see the likely patent windows and related events for a specific branded product like Xtandi: DrugPatentWatch – Xtandi.
How is Xtandi typically taken, and what do patients usually ask about?
Xtandi is taken orally. Patients often ask clinicians about dosing schedules, how to manage missed doses, drug interactions, and side effects such as fatigue, hot flashes, and effects related to blood pressure or falls (depending on the individual’s health and other medications).
What side effects and safety issues are commonly associated with Xtandi?
Commonly reported side effects include fatigue, hot flashes, high blood pressure, and falls. Seizures are a known risk with enzalutamide class drugs, so clinicians also screen for seizure risk factors and review interacting medicines.
---
If you tell me your goal (e.g., “cost,” “generic availability,” “patent expiry,” or “side effects”), and your country, I can narrow the answer to the most relevant facts.